Neovascular glaucoma treated by intravitreal triamcinolone acetonide
نویسندگان
چکیده
منابع مشابه
Intravitreal triamcinolone acetonide as adjunctive treatment for neovascular glaucoma.
Neovascular glaucoma is a challenging disease in its pathogenesis and treatment. Ischemic retinopathies can lead to neovascular glaucoma due to newly formed vessels on the iris surface and anterior chamber angle. Eyes with neovascular glaucoma can exhibit high intraocular pressure, usually treated by retinal coagulation, cyclodestructive procedures, or drainage procedures. Based on experimental...
متن کاملPatients treated with intravitreal triamcinolone acetonide
Correspondence: Pier Enrico Gallenga University Eye Clinic, G.D’Annunzio University, Chieti, Italy Email [email protected] Patients treated with intravitreal triamcinolone acetonide The paper by Kocabora and coworkers (2008) underlines the message that patients treated with intravitreal triamcinolone acetonide are at risk of increased intraocular pressure (IOP) even after the clearance period o...
متن کاملSecondary chronic open-angle glaucoma after intravitreal triamcinolone acetonide.
American cooperative group in 1972, the Intergroup Rhabdomyosarcoma Study Group has undertaken a series of clinical trials that have employed chemotherapy, surgery, and irradiation for local control. The addition of systemic chemotherapy has markedly improved long-term survival in affected children. These children now have an excellent prognosis with current multimodality therapy. A recent revi...
متن کاملViscocanalostomy for refractory glaucoma secondary to intravitreal triamcinolone acetonide injection.
Intravitreal injection of triamcinolone acetonide (IVTA) has gained widespread use in the treatment of a variety of neovascular and inflammatory intraocular conditions, including proliferative diabetic retinopathy, chronic cystoid macular edema, and chronic uveitis. Intraocular pressure (IOP) greater than 21 mm Hg occurs in approximately 42% of eyes following IVTA. Most of these patients are su...
متن کاملIntravitreal Injection of Triamcinolone Acetonide
The introduction of pars plana vitrectomy in clinical ophthalmology by Robert Machemer and colleagues was a profound paradigm change which opened up new avenues for the treatment of ocular diseases, such as proliferative vitreoretinopathy, which up to that time had been incurable [79]. It was again Robert Machemer who together with Yasuo Tano, Gholam Peyman, Stephan Ryan and other researchers f...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Acta Ophthalmologica Scandinavica
سال: 2003
ISSN: 1395-3907
DOI: 10.1034/j.1600-0420.2003.00130.x